Using biomarkers to predict clinical outcomes in multiple sclerosis.

Daniel Castle1,2, Ray Wynford-Thomas1,2, Sam Loveless1,2

  • 1Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Practical Neurology
|June 28, 2019
PubMed
Summary

Identifying reliable biomarkers is crucial for predicting long-term multiple sclerosis (MS) outcomes and personalizing treatment. Combining multiple biomarkers may improve prediction accuracy for this complex neurodegenerative disease.

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.3K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.5K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
106.8K